Pretreatment of mice with OMVs prior to chemical induction of colitis results in reduced expression of the inflammatory enzymes cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS), reduced production of inflammatory cytokines, and an overall decrease in symptoms (Fábrega et al., 2017). This evidence concerns the gene NOS2 and colitis.